Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes

MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) --  Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the leading neurohealth therapies in the world, today announced that it is set to join the broad-market Russell 3000^® Index and the small-cap Russell 2000^® Index at the conclusion of the Russell indexes annual reconstitution, effective after the US market opens on June 30, 2025.

Read more at globenewswire.com